SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-044886
Filing Date
2024-02-26
Accepted
2024-02-23 21:28:02
Documents
14
Period of Report
2024-02-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics

Document Format Files

Seq Description Document Type Size
1 8-K d785996d8k.htm   iXBRL 8-K 41768
  Complete submission text file 0001193125-24-044886.txt   162449

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ibrx-20240222.xsd EX-101.SCH 2862
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibrx-20240222_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibrx-20240222_pre.xml EX-101.PRE 10820
15 EXTRACTED XBRL INSTANCE DOCUMENT d785996d8k_htm.xml XML 3501
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

IRS No.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 24673405
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)